The company's platform tracks and offers insights into mitochondrial health by measuring oxygen consumption, enabling users to get personalized and actionable recommendations on improving their daily lifestyle. MyChon is making previously expensive and complicated mitochondria technologies accessible to a larger market in a convenient way. Their technology originated at the David Geffen School of Medicine at UCLA and is designed to help people access and understand cellular health through genetic research.